Big Pharma is waking up to the booming field of gene editing. Here are the top 18 biotechs to know in 2022 that are poised to grab the drug industry's attention.
Business Insider
|
January 31, 2022
X min read
Business Insider
|
January 31, 2022
Share on Social
More like this
Media
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
July 27, 2026
Read Now
Press
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
July 27, 2026
Read Now
